It also affects the bodys physical arousal response
Multi-indication label expansion: Semaglutide approved across obesity, cardiovascular risk reduction, MASH, and sleep apnea creates a total addressable patient population of approximately 640 million globally nearly four times the obesity-only base adding new prescriber populations including cardiologists, hepatologists, and sleep medicine specialists
details of registered studies can be found on ClinicalTrials.gov
Pregnancy complications, including miscarriage or ectopic pregnancy, should be excluded early in the assessment of any change in bleeding pattern
A 2025 study concluded that GLP-1 drugs can help improve heart and brain health but might also cause kidney and gastrointestinal issues
Change history 23 March 2017 A correction has been published and is appended to both the HTML and PDF versions of this paper